Literature DB >> 3548816

Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains.

I Kato, J Schrode, W J Kohr, M Laskowski.   

Abstract

The complete amino acid sequence of chicken ovomucoid (OMCHI) is presented. OMCHI consists of three tandem domains, each homologous to pancreatic secretory trypsin inhibitor (Kazal) and each with an actual or putative reactive site for inhibition of serine proteinases. The major reactive site for bovine beta-trypsin is the Arg89-Ala peptide bond in the second domain. The equilibrium constant for hydrolysis of this peptide bond, K0hyd, is 1.85. The first and third domains of OMCHI are relatively ineffective inhibitors of several serine proteinases against which they were tested. OMCHI is a mixture of two forms: the major form with all of the amino acid residues and a minor form with Val134-Ser135 deleted. This polymorphism is present in all chicken eggs and is the result of ambiguous excision at the 5' end of the F intron. Procedures are given for preparation of modified chicken ovomucoid, OMCHI (in which the Arg89-Ala bond is hydrolyzed), of the first domain, OMCHI1 (residues 1-68), of the second domain, OMCHI2 (residues 65-130), and of the third domain, OMCHI3 (residues 131-186). In the case of the third domain, both the Asn175 glycosylated form, OMCHI3(+), and the carbohydrate-free form, OMCHI3(-), were obtained. These isolated native domains are useful in many studies of ovomucoid behavior.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548816     DOI: 10.1021/bi00375a027

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  24 in total

1.  Amino acid sequences of ovomucoid third domain from 25 additional species of birds.

Authors:  M Laskowski; I Apostol; W Ardelt; J Cook; A Giletto; C A Kelly; W Y Lu; S J Park; M A Qasim; H E Whatley
Journal:  J Protein Chem       Date:  1990-12

Review 2.  The relationships between the biochemical properties of allergens and their immunogenicity.

Authors:  T Musu; C Grégoire; B David; J P Dandeu
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Glycopeptide Site Heterogeneity and Structural Diversity Determined by Combined Lectin Affinity Chromatography/IMS/CID/MS Techniques.

Authors:  Feifei Zhu; Jonathan C Trinidad; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-04       Impact factor: 3.109

4.  Spink13, an epididymis-specific gene of the Kazal-type serine protease inhibitor (SPINK) family, is essential for the acrosomal integrity and male fertility.

Authors:  Li Ma; Heguo Yu; Zimei Ni; Shuanggang Hu; Wubin Ma; Chen Chu; Qiang Liu; Yonglian Zhang
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

5.  Evolution of protein inhibitors of serine proteinases: positive Darwinian selection or compositional effects?

Authors:  D Graur; W H Li
Journal:  J Mol Evol       Date:  1988 Dec-1989 Feb       Impact factor: 2.395

6.  Basic trypsin-subtilisin inhibitor from marine turtle egg white: hydrodynamic and inhibitory properties.

Authors:  P C Sil; T K Chaudhuri; N K Sinha
Journal:  J Protein Chem       Date:  1993-02

7.  Amino acid sequences of ovomucoid third domains from 27 additional species of birds.

Authors:  I Apostol; A Giletto; T Komiyama; W Zhang; M Laskowski
Journal:  J Protein Chem       Date:  1993-08

8.  Thermodynamics of unfolding for turkey ovomucoid third domain: thermal and chemical denaturation.

Authors:  L Swint; A D Robertson
Journal:  Protein Sci       Date:  1993-12       Impact factor: 6.725

9.  Proteolysis of the 85-kilodalton crystalline cysteine proteinase inhibitor from potato releases functional cystatin domains.

Authors:  T A Walsh; J A Strickland
Journal:  Plant Physiol       Date:  1993-12       Impact factor: 8.340

10.  A structural study of the asparagine-linked oligosaccharide moiety of duck ovomucoid.

Authors:  N Takahashi; T Matsuda; K Shikami; I Shimada; Y Arata; R Nakamura
Journal:  Glycoconj J       Date:  1993-12       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.